Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
09/2003
09/03/2003EP1339655A1 Transfer hydrogenation process and catalyst
09/03/2003EP1194403B1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
09/03/2003EP1177170B1 Fluoroalkanesulfonylazide monomers and copolymers thereof
09/03/2003EP0977741B1 Substituted phenyl derivatives, their preparation and use
09/03/2003EP0977733B1 Arylsulfonylamino hydroxamic acid derivatives
09/03/2003EP0775689B1 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1120150C Meta-aminophenylsulfonyl J acid, its synthesizing process and its usage
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613801 Method for the synthesis of compounds of formula I and their uses thereof
09/02/2003US6613764 Aspartic protease inhibitors
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
08/2003
08/28/2003WO2003070717A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/28/2003WO2003070694A2 Method for treating an imide organic solution bearing a sulphonyl group
08/28/2003WO2003070691A1 N-hydroxycarboxamide derivative
08/28/2003WO2003070690A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/28/2003WO2003070682A1 NON-COVALENT INHIBITORS OF AmpC ß-LACTAMASE
08/28/2003WO2003049698A3 Substituted hydrazones as inhibitors of cyclooxygenase-2
08/28/2003WO2003029169A3 Hydroxypropylamines
08/28/2003WO2003028641A3 Mch receptor antagonists
08/28/2003WO2003016285A8 Method of preparing 4-(imidazole-1-il)benzenesulphonamide derivatives
08/28/2003US20030162818 Drugs such as N-(2-(3-Benzyloxybenzamido)benzenesulfonyl) benzamide, used as acetyl-CoA carboxylase inhibitors for prevention of hyperlipemia, hypertension, arteriosclerosis, necrosis or insulin resistance
08/28/2003US20030162817 Pentafluorobenzenesulfonamides and analogs
08/28/2003US20030162814 Amines such as 2-(3-(N-hydroxyamidino)phenylamino)-N-(2'-sulfamoylbiphenyl-4-yl)-2 -methylpropionamide, used as anticoagulants or for prophylaxis of arteriosclerosis, angina pectoris, restinosis or metastasis
08/28/2003US20030162813 Heterocyclic nitrogen comppounds such as 4-(5-methyl-3-phenyl-isoxazol-1-yl)benzenesulfonamide, used as non-steroidal antiinflammatory agents or antiarthritic agents; cyclooxygenase inhibitors
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/28/2003US20030162755 Halo active aromatic sulfonamide organic compounds and uses therefor
08/28/2003US20030162690 Bood anticoagulant
08/28/2003US20030162096 Solvent have a highly polar amide function, and preferably combine with a salt soluble in the solvent, having an anion with a delocalized charge, and atleast one polymer to form an electrolyte
08/28/2003CA2474785A1 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/27/2003EP0906906B1 Process for preparing optically active 2-piperazinecarboxylic acid derivatives
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003EP0842157B1 Herbicidal sulphonylamino(thio)carbonyl compounds
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/26/2003US6610882 Affinity for bradykinin receptors; antithrombotics
08/26/2003US6610747 Phenoxybenzylamine derivatives as SSRIs
08/26/2003US6610710 Inflammatory bowel diseases, diabetes, tumor proliferation and tumor metastasis.
08/26/2003US6610689 Viricides
08/23/2003CA2473075A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/22/2003CA2372731A1 Oligo-amine/oligo-carboxy sulfonamides
08/21/2003WO2003027075A3 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/21/2003WO2002020463A3 Fxr modulators
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158443 Combinatorial active compound synthesis and its intermediates
08/21/2003US20030158406 Enzyme inhibitor treating autoimmune diseases, Alzheimer's disease, atherosclerosis
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158231 Sulfonamide compounds as protease inhibitors
08/21/2003US20030158155 Mmp-12 inhibitors
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP0923542B1 Aryl substituted cyclic amines as selective dopamine d3 ligands
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/19/2003US6608715 Wavelength converter using Bragg-grating
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608100 HIV protease inhibitors based on amino acid derivatives
08/19/2003US6608057 Compounds useful as reversible inhibitors of cathepsin S
08/19/2003CA2260337C Therapeutic agents
08/19/2003CA2085347C Novel cyclic aminophenylacetic acid derivative, production therof, and immune response modulator containing the same as active ingredient
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003024955A3 Small molecule inhibitors of caspases
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/13/2003EP1334966A1 Process for preparation of optically active sulfonamides and intermediates for their synthesis
08/13/2003EP1334719A2 Pentafluorobenzenesulfonamides and analogs
08/13/2003EP1334087A1 Cycloalkylfluorosulfonamide derivatives
08/13/2003EP1334086A1 Phenoxyphenyl alkane sulfonates
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003CN1436168A Beta-amino acid nitrile derivs.
08/12/2003US6605645 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/12/2003US6605124 Naphthol hair dyes for keratinous fibers
08/07/2003WO2003064378A2 Novel compounds that inhibit factor xa activity
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2003063576A2 Arylsulfonamidobenzylic compounds
08/07/2003US20030149110 For use as as neuro-protective agents for therapy of conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, anxiety, convulsions, aminoglycoside antibiotics-induced hearing loss, migraine
08/07/2003US20030149094 Compositions comprising ether compounds and pharmaceutical uses therefor
08/07/2003US20030149083 For therapy of inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis
08/07/2003US20030149015 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
08/07/2003US20030148211 Sulfonium salt and use thereof
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2474433A1 Arylsulfonamidobenzylic compounds
08/07/2003CA2473164A1 Novel compounds that inhibit factor xa activity
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/06/2003EP1084103B1 New 3-aryl-2-hydroxypropionic acid derivative (i)
08/06/2003EP0912093B1 (hetero)aryl sulphonyl ureas with an iminofunction, the preparation and use thereof as herbicides and plant growth regulators
08/06/2003EP0874800B1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
08/06/2003EP0865419B1 Indane dimer compounds and their pharmaceutical use
08/05/2003US6602878 Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
07/2003
07/31/2003WO2003062212A1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
07/31/2003WO2003062191A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/31/2003WO2003061643A1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
07/31/2003WO2002094767A3 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
07/31/2003WO2002030514A3 Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of hiv infection with hiv protease inhibitors
07/31/2003US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents
07/31/2003US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis
07/31/2003US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 177